Selective Estrogen Receptor Modulators (SERMs) can be a cornerstone of pharmaceutical PCT interventions. They perform as competitive inhibitors at estrogen receptors from the hypothalamus when exhibiting tissue-selective agonist or antagonist Houses all through the entire body. SERMs are essential in regulating post cycle estrogen production and mi